Sulforaphane

Research Papers and Clinical Studies

Current research on sulforaphane spans multiple therapeutic areas, with studies investigating its potential in neurological conditions, cardiovascular health, and cancer treatment.

Neurological Research

Recent preclinical studies have explored sulforaphane's neuroprotective properties through multiple mechanisms. A 2026 study examined sulforaphane's effects in a multiple sclerosis-like pathology model, comparing it to established treatments omaveloxolone and dimethyl fumarate for neuroprotection and systemic recovery (PMID: 42426148). The research suggests sulforaphane may work through activation of Nrf2 neuroprotective pathways, which has been identified as a potential treatment approach for Parkinson's disease (PMID: 42442915).

Several review papers have evaluated sulforaphane alongside other phytochemicals as emerging therapeutic strategies for Alzheimer's disease, though these represent integrative reviews of existing evidence rather than new clinical data (PMID: 42382677).

Cardiovascular and Cellular Protection

Laboratory research has demonstrated sulforaphane's protective effects on heart muscle cells (cardiomyoblasts) under stress conditions, working through enhanced mitochondrial-endoplasmic reticulum communication and autophagy pathways (PMID: 42413811). Additional studies have investigated its role in bone metabolism, showing that glucosinolate-rich broccoli microgreen extracts containing sulforaphane promoted bone cell differentiation and antioxidant responses in human stromal cells (PMID: 42429589).

Clinical Trial Evidence

Several completed clinical trials have tested sulforaphane in different patient populations, though detailed results are not provided in the available evidence:

• A Phase 2 trial (NCT02970682) evaluated SFX-01, a sulforaphane-based treatment, in metastatic breast cancer patients
• A combined Phase 1/2 study (NCT02561481) tested sulforaphane in children with autism spectrum disorder
• A Phase 2 trial (NCT01228084) examined sulforaphane treatment in patients with recurrent prostate cancer
• Phase 1 safety studies have been conducted in healthy males (NCT02055716)
• One study investigated broccoli sprout effects on immune system responsiveness (NCT01357070)

Production and Bioavailability Research

Food science research has explored optimizing sulforaphane production, with studies examining how temperature affects microbial processes that convert precursors to bioactive sulforaphane during broccoli fermentation (PMID: 42409534).

Important Note: While these studies suggest potential therapeutic applications, the evidence provided does not include detailed results or efficacy data from the clinical trials. Patients considering sulforaphane supplementation should consult healthcare providers, as this information is for educational purposes only and not intended as medical advice.